Phase II study of fotemustine in patients with advanced ovarian carcinoma. A trial of the EORTC Gynecological Cancer Group

Author: Aapro M.S.   van Wijk F.H.   van der Burg M.E.L.   ten Bokkel Huinink W.   Vergote I.   Guastalla J.P.   Rosso R.   Kobierska A.   Beex L.V.A.   Namer M.   Splinter T.E.W.   Vermorken J.B.  

Publisher: Elsevier

ISSN: 0959-8049

Source: European Journal of Cancer, Vol.39, Iss.8, 2003-05, pp. : 1141-1143

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content